中国寄生虫学与寄生虫病杂志 ›› 2003, Vol. 21 ›› Issue (2): 4-79.

• 论著 • 上一篇    下一篇

日本血吸虫SjE16基因的原核表达及其免疫诊断应用潜能

王兆军1,胡薇2,沈大康1,武小文3,王聚君2,韩泽广3,薛纯良1
  

  1. 1 上海第二医科大学病原生物学教研室,上海 200025 2 中国疾病预防控制中心寄生虫病预防控制所,上海 200025 3 国家人类基因组南方研究中心,上海 200025
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2003-04-30 发布日期:2003-04-30

Prokaryotic Expression of Gene Encoding Schistosoma japonicum SjE16 and its Potential Application in Immunodiagnosis

WANG Zhao-jun1,HU Wei2,SHEN Da-kang1,WU Xiao-wen3,WANG Ju-jun2,HAN Ze-guang3,XUE Chun-Hang1
  

  1. 1 Department of Pathogenic Biology,Shanghai Second Medical University,Shanghai 200025,2 Institute of Parasitic Diseases,Chinese Center for Disease Control and Prevention,Shanghai 200025,3 National Human Genome Center at Shanghai,Shanghai 201323
  • Received:1900-01-01 Revised:1900-01-01 Online:2003-04-30 Published:2003-04-30

摘要:   目的亚克隆和表达日本血吸虫钙结合蛋白SjE16的编码基因,初步研究其免疫反应性。方法根据表达序列标签(ESTs)测序的结果设计引物,从含有钙结合蛋白基因片段的克隆中扩增得到该编码基因,亚克隆人原核表达载体pGEX4T-1中表达,然后用ELISA方法初步检测重组蛋白的免疫反应性。结果成功克隆和表达了日本血吸虫SjE16基因,该重组蛋白用于血吸虫病免抗体ELISA检测,其特异性和敏感性分别为94.1%(16/17)和88.2%(15/17)。非治疗组在感染后9~11wk抗体水平升高,并在感染后21wk仍维持高水平,而治疗组血清抗SjE16抗体水平在治疗后11wk下降至感染前水平。SjE16用于检测血吸虫病患者血清中的抗体,其特异性为98.3%(57/58),急性患者和慢性患者的敏感性分别为85.5%(53/62)和70.2%(40/57)。结论获得了SjE16的重组蛋白,该蛋白能被日本血吸虫病患者的血清所识别,且在病兔药物治疗后迅速下降。SjE16重组蛋白具有诊断现感染和疗效考核的潜能。

关键词: 日本血吸虫, 钙结合蛋白, 免疫诊断

Abstract:  Objective To sub-clone and express the gene encoding Schistosoma japonicum calcium-binding protein (SJE16) and study its immunological response. Methods The specific primers were designed according to the expressed sequence tags(ESTs) sequence, which was used for amplification of the encoding sequence from the cDNA clone containing SJE16. The gene was subcloned into pGEX4T-l plasmid and expressed. The rSjE16 was tested for its immunological response by ELISA. Results The gene encoding Schistosoma japonicum SJE16 was cloned and expressed successfully. The immuno-genicity and diagnostic potential of rSjE16 were investigated. It was demonstrated by immunoassay in rabbits that the specificity and sensitivity of the test were 94.1% (16/17) and 88. 2% (15/17), respectively, and the level of antibody liter of the untreated group reached a peak at 9 - 11 wk post infection and maintained high at least for 21 wk post infection, while the antibody level in the treated group rapidly decreased to pre-infection level in 11 wk after treatment. In human, the specificity of the test was 98.3% (57/58); the sensitivity of acute and chronic patient serum assay was 85.5% (53/62) and 70.2% (40/57), respectively. Conclusion The recombinant protein of SjE16 (rSjE16) was acquired. It can be recognized by the sera from schistosomiasis patients, and the level of antibodies decreased quickly after treatment in experimental rabbits, which implicates the potential value for the evaluation of chemotherapy and detection of active infection.

Key words: Schistosoma Joponicum, calcium-binding protein, immunodiagncsis